Joetsu, Japan

Hideki Takeuchi


 

 

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 12(Granted Patents)


Location History:

  • Nagano, JP (2006 - 2009)
  • Joetsu, JP (2013 - 2020)

Company Filing History:


Years Active: 2006-2020

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Hideki Takeuchi

Introduction

Hideki Takeuchi is a prominent inventor based in Joetsu, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 12 patents. His work focuses on developing innovative compounds that enhance solubility and stability, which are crucial for effective drug formulation.

Latest Patents

Among his latest patents is the invention of a salt of a fused heterocyclic derivative and its crystal form. This invention provides a specific compound, 3-[2-fluoro-5-(2,3-difluoro-6-methoxybenzyl-oxy)-4-methoxyphenyl]-2,4-dioxo-1,2,3,4-tetrahydrothieno[3,4-d]pyrimidine-5-carboxylic acid choline salt. This compound is noted for its excellent solubility and storage stability, making it a valuable addition to pharmaceutical applications.

Career Highlights

Hideki Takeuchi is currently associated with Kissei Pharmaceutical Co., Ltd., where he continues to innovate and develop new pharmaceutical solutions. His expertise in the field has led to numerous advancements that benefit both the industry and patients.

Collaborations

Throughout his career, Takeuchi has collaborated with notable colleagues, including Yuichiro Kai and Kenji Yokoyama. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Hideki Takeuchi's contributions to the pharmaceutical industry through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to impact the field positively, paving the way for future advancements in drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…